Post-resuscitation myocardial microcirculatory dysfunction is ameliorated with eptifibatide

Area of Science:

• Cardiology
• Critical Care Medicine
• Pharmacology

Background:

• Post-cardiac arrest syndrome is characterized by impaired myocardial microcirculation.
• Platelet IIb/IIIa glycoprotein receptor inhibition has shown promise in improving microvascular function.
• The study investigates eptifibatide's effect on myocardial microcirculation after cardiac arrest and resuscitation.

Purpose of the Study:

• To evaluate the efficacy of eptifibatide in preserving myocardial microcirculation function post-cardiac arrest and resuscitation.
• To assess the impact of eptifibatide on left ventricular systolic and diastolic function after cardiac arrest.

Main Methods:

• A prospective, randomized, blinded, placebo-controlled study in swine.
• Four groups received eptifibatide during CPR, after resuscitation, during and after resuscitation, or placebo.
• Coronary flow reserve and left ventricular function were measured pre-arrest and post-resuscitation.

Main Results:

• Eptifibatide treatment preserved coronary flow reserve, indicating normal microcirculatory function.
• Placebo-treated animals exhibited impaired microcirculatory function.
• Left ventricular function declined similarly in both eptifibatide and placebo groups.

Conclusions:

• Eptifibatide prevents myocardial microcirculation dysfunction following cardiac arrest and resuscitation.
• Eptifibatide did not improve, and may have transiently worsened, left ventricular dysfunction.
• A multi-modality treatment approach is likely necessary for addressing post-cardiac arrest ventricular dysfunction.